The clinical questions patients ask about peptide therapy at THE WELLNESS CO. — what peptides are, regulatory status, candidacy, monitoring, what they can and can't do. Each answer is medically reviewed by Dawn Philp, FNP-BC and reflects how we actually practice: conservative dosing, structured monitoring, honest regulatory framing.
For peptide-specific questions, see the dedicated molecule pages: Sermorelin, BPC-157, CJC-1295/Ipamorelin, PT-141, NAD+, and AOD-9604.
Short chains of amino acids that act as signaling molecules. Targeted receptor binding produces defined physiologic effects depending on the peptide.
Read the full answer →Some are (Vyleesi/PT-141 for HSDD). Most therapeutic peptides are prescribed off-label or compounded. Honest regulatory status disclosed for every peptide we offer.
Read the full answer →Hormones are typically larger, broader-acting molecules. Peptides are smaller, shorter-acting, more targeted signaling molecules. Complementary, not interchangeable.
Read the full answer →Safety depends on the peptide, dose, source, and monitoring. Compounding-pharmacy-sourced peptides with medical oversight are very different from research-chemical channels.
Read the full answer →PT-141: hours. BPC-157: 4-8 weeks. Sermorelin/CJC-1295/Ipamorelin: 8-12 weeks for sleep and recovery, 3-6 months for body composition.
Read the full answer →Active cancer (especially GH-axis peptides), pregnancy/breastfeeding, certain endocrine disorders without specialist co-management, specific medication interactions.
Read the full answer →Upload existing bloodwork. Our clinical team reads it through the CLARITY framework — free.
Get Your Free Lab Review →One consultation. Your biomarkers map the protocol.
Book Your Consultation